Cetera Investment Advisers’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Cetera Investment Advisers's EXAS Position: Q1 2026 in Review
Cetera Investment Advisers sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 65,548 shares — an estimated $6.66M sold.
Cetera Investment Advisers first reported a position in EXAS in Q4 2020 and held it in 21 quarters. The position peaked at $7.44M in Q1 2024. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Cetera Investment Advisers reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Cetera Investment Advisers sold 65,548 Exact Sciences shares in Q1 2026, an estimated $6.66M.
- Cetera Investment Advisers first reported a position in Exact Sciences in Q4 2020 and held it in 21 quarters.
- Cetera Investment Advisers's Exact Sciences position peaked at $7.44M in Q1 2024.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.